Changing natalizumab dosing frequency reduced risk for PML

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Changing natalizumab dosing frequency reduced risk for PML

Post by MSUK »

Changing natalizumab dosing frequency reduced risk for Progressive Multifocal Leukoencephalopathy (PML)

A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health in New York…Read more - http://www.ms-uk.org/changing-natalizum ... opathy-pml

Image
MS-UK - http://www.ms-uk.org/
ElliotB
Family Elder
Posts: 2058
Joined: Mon Feb 03, 2014 4:08 pm

Re: Changing natalizumab dosing frequency reduced risk for P

Post by ElliotB »

I have to wonder why anyone would take a medication known to cause or potentially cause something as serious as PML. This is not the only medication that has this very, very serious risk.
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Tysabri (Antegren, Natalizumab)”